Candel Therapeutics (CADL) Shares Outstanding (2020 - 2025)

Candel Therapeutics has disclosed Shares Outstanding across 6 years of filings, most recently posting $54.9 million for Q4 2025.

• Shares Outstanding for Q4 2025 came in at $54.9 million, up 17.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $54.9 million (up 17.28% YoY), and the FY2025 annual result was $54.9 million, up 17.28% from the prior year.
• Shares Outstanding came in at $54.9 million for Q4 2025 at Candel Therapeutics, roughly flat from $54.9 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $55.0 million in Q2 2025 to a low of -$122608.0 in Q3 2022.
• The 5-year median for Shares Outstanding is $29.0 million (2023), against an average of $29.0 million.
• Across the five-year window, Shares Outstanding sank 100.43% in 2023 and soared 24136.01% in 2024, its largest moves.
• Candel Therapeutics' Shares Outstanding stood at $28.7 million in 2021, then climbed by 1.23% to $29.0 million in 2022, then advanced by 0.59% to $29.2 million in 2023, then soared by 60.24% to $46.8 million in 2024, then rose by 17.28% to $54.9 million in 2025.
• The last three Shares Outstanding figures came in at $54.9 million (Q4 2025), $54.9 million (Q3 2025), and $55.0 million (Q2 2025), per Business Quant data.